Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers

The management of non-small cell lung cancer (NSCLC) has transformed with the discovery of therapeutically tractable oncogenic drivers. In addition to activating driver mutations, gene fusions or rearrangements form a unique sub-class, with anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Aaron C., Itchins, Malinda, Khasraw, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073114/
https://www.ncbi.nlm.nih.gov/pubmed/32093103
http://dx.doi.org/10.3390/ijms21041416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073114/
https://www.ncbi.nlm.nih.gov/pubmed/32093103
http://dx.doi.org/10.3390/ijms21041416

Ejemplares similares